|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| G01N 33/66 | (2006.01) |
| (11) | Number of the document | 2376915 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09837207.1 |
| Date of filing the European patent application | 2009-12-31 | |
| (97) | Date of publication of the European application | 2011-10-19 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-29 |
| (46) | Date of publication of the claims translation | 2017-06-26 |
| (86) | Number | PCT/US2009/069941 |
| Date | 2009-12-31 |
| (87) | Number | WO 2010/078511 |
| Date | 2010-07-08 |
| (30) | Number | Date | Country code |
| 142291 P | 2009-01-02 | US | |
| 164365 P | 2009-03-27 | US | |
| 649094 | 2009-12-29 | US |
| (72) |
CRAWFORD, Brett E., US
BROWN, Jillian R., US
GLASS, Charles A., US
|
| (73) |
BioMarin Pharmaceutical Inc.,
105 Digital Drive, Novato, CA 94949,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | MPS IIIB sutrikimo diagnostikos būdas |
| METHOD FOR DIAGNOSING MPS IIIB DISORDER |
| Payment date | Validity (years) | Amount | |
| 2024-11-21 | 16 | 347.00 EUR |
| 2025-12-31 |